[1] Ignarro LJ，Buga GM，Wood KS，et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide[J]. Proc Natl Acad Sci USA，1987，84(22)：9265-9269.

[2] Patel RP，Mc Andrew J，Sellak H，et al. Biological aspects of reactive nitrogen species [J]. BBA-Bioenerg，1999，1411(2)： 385-400.

[3] Ying L，Hofseth LJ. An emerging role for endothelial nitric oxide synthasein chronic inflammation and cancer[J]. Cancer Res，2007，67(4)：1407-1410.

[4] Gal A，Wogan GN. Mutagenesis associated with nitric oxide production in transgenic SJL mice[J]. Proc Natl Acad Sci USA， 1996，93(26)：15102-15107.

[5] Choi BM，Pae HO，Jang SI，et al. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator[J]. J Biochem Mol Biol，2002，35(1)：116-126.

[6] Von KA，Brune C. Cyclooxygenase-2：an essential regulator of NO-mediated apoptosis[J]. FASEBJ，1997，11(11)：887-895.

[7] Ziche M，Morbidelli L. Nitric oxide and angiogenesis[J]. J Neuro oncol ，2000，50(1)：139-148.

[8] Lala PK，Orucevic A. Role of nitric oxide in tumor progression：lessons from experimental tumors[J]. Cancer Metastasis Rev，1998，17(1)：91-106.

[9] Choudhari SK，Chaudhary M，Baqde，S，et al. Nitric oxide and cancer：a review[J].World J Surq Oncol，2013，11(118)： 1-11.

[10] Switzer CH，Cheng RY-S，Ridnour LA，et al. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signalling in estrogen receptor negative breast cancer[J]. Breast Cancer Res，2012，14(5)：125.

[11] Tschugguel W，Knogler W，Czerwenka K，et al. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia [J]. Br J Cancer，1996，74(9)：1423-1426.

[12] Pance A. Nitric oxide hormones and breast cancer. Nitric oxide and hormones in breast cancer：allies or enemies ? [J]. Future Oncol，2006，2(2)：275–288.

[13] Chang K，Lubo Z. Review article：steroid hormones and uterine vascular adaptation to pregnancy[J]. Reprod Sci， 2008，15(4)：336-348.

[14] Naidu MSK，Suryakar AN，Swami SC，et al. Oxidative stress and antioxidant status in cervical cancer patients[J]. Indian J Clin Bio chem，2007，22(2)：140-144.

[15] Tavares-Murta BM，de Resende AD，Cunha FQ，et al. Local profile of cytokines and nitric oxide in patients with bacterial vaginosis and cervical intraepithelial neoplasia[J]. Eur J Obstet Gynecol Repro Biol，2008，138(1)：93-99.

 [16] Wei L，Gravitt PE，Song H，et al. Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells[J]. Cancer Res，2009，69(11)：4878-4884.

[17] 魏雪敏，汪  倩，高蜀君，等. 一氧化氮与HPV感染的关系及其对子宫颈癌细胞增殖与凋亡的影响[J]. 中华妇产科杂志，2011，46(4)：260-265.

[18] Chen GG，Lee TW，Xu H，et al. Increased inducible nitric oxide synthase in lung carcinoma of smokers[J]. Cancer， 2008，112(2)：372-381.

[19] Forbes TA，Hopkins L，Schneider B，et al. Potential role of nitric oxide in chromium-induced lung carcinogenesis[J]. Cancer Res，2012，72(Sup 8)：54-56.

[20] Beckman JS，Ischiropoulos H，Zhu L，et al. Kinetics of superoxide dismutase and iron-catalyzed nitration of phenolics by peroxynitrite[J]. Arch Biochem Biophys，1992，298(2)： 438-445.

[21] Masri FA，Comhair SAA，Koeck T，et al. Abnormalities in nitric oxide and its derivatives in lung cancer [J]. Am J Respir Crit Care Med，2005，172(5)：597-605.

[22] Feng CW，Wang LD，Jiao LH，et al. Expression of p53，inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions： correlation with clinical features[J]. BMC Cancer，2002， 2(1)：8.

[23] Broholm H，Rubin I，Kruse A，et al. Nitric oxide synthase expression and enzymatic activity in human brain tumors[J]. Clin Neuropathol，2003，22(6)：273-281.

[24] 赵莉萍，胡咏梅. 幽门螺杆菌诱导大鼠胃上皮细胞凋亡与一氧化氮相关性研究[J]. 蚌埠医学院学报，2013，38(7)：784-786.

[25] 张  雷. 食管鳞癌组织诱导型一氧化氮合酶和增殖细胞核抗原的表达及意义[J]. 中华消化病与影像杂志，2013，3(4)：13-16.

[26] Yagihashi N，Kasajima H，Sugai S，et al. Increased in situ expression of nitric oxide synthase inhuman colorectal cancer [J]. Virchows Arch ，2001，436(2)：109-114.

[27] Cobbs CS，Brenman JE，Aldape KD，et al. Expression of nitric oxide synthase in human central nervous system tumors[J]. Cancer Res，1995，55(4)：727-730.

[28] Rasheed MH，Beevi SS，Geetha A. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma[J]. Oral Oncol，2007，43(4)：333-338.

[29] Korde SD，Basak A，Chaudhary M，et al. Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma[J]. Oncology，2011，80(5/6)：382-389.

[30] Cooper RG，Magwere T. Nitric oxide-mediated pathogenesis during nicotine and alcohol consumption[J]. Indian J Physiol Pharmacol ，2008，52(1)：11-18.

[31] 陈  华. 喉癌患者手术及化疗前后一氧化氮水平变化及其意义[J]. 检验医学与临床，2013，10(20)：2677-2678.

[32] Singh S，Gupta AK. Mini review nitric oxide：role in tumour biology and iNOS/NO-based anticancer therapies[J]. Cancer Chemother Pharmacol，2011，67(6)：1211-1224.

[33] Aranda E，López-Pedrera C，De La Haba-Rodriguez JR，et al. Nitric oxide and cancer： the emerging role of S-nitrosylation [J]. Curr Mol Med，2012， 12(1)：50-67.

[34] Huerta S，Chilka S，Bonavida B. Nitric oxide donors：novel cancer therapeutics (Review) [J]. Int J Oncol，2008，33(5)： 909-927.

[35] Bonavida B，Baritaki S，Huerta-Yepez S，et al. Novel therapeutic applications of nitric oxide donors in cancer：roles in chemo- and immunosensitization to apoptosis and inhibition of metastases[J]. Nitric oxide，2008，19(2)：152-157.

[36] 彭金娥，潘敬新. 一氧化氮在肿瘤治疗中的多重作用[J]. 肿瘤，2012，32(1)：70-71.

[37] Seabra AB，Duran N. Nitric oxide-releasing vehicles for biomedical applications[J]. Mater Chem， 2010，20(9)：1624-1637.

[38] Saraiva J，Marotta-Oliveira SS，Cicillini SA，et al. Nanocarriers for nitric oxide delivery[J]. J Drug Deliv，2011， 1(1)：1-16.

[39] Kanayama N，Yamaguchi K，Nagasaki. PEGylated polymer micelle-based nitric oxide (NO) photodonor with NO-mediated antitumor activity[J]. Chem Lett ，2010，39(9)：1008-1009.

[40] Cabrales P，Han G，RocheC，et al. Sustained release nitric oxide from long-lived circulating nanoparticles[J]. Free Radic Biol Med，2010，49(4)：530-538.

[41] Marquele-Oliveira F，Santana DC，Taveira SF，et al. Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration：improvement in skin stability and in nitric oxide release by visible light irradiation[J]. J Pharm Biomed Anal，2010，53(4)：843-851.

[42] Stevens EV，Carpenter AW，Shin JH，et al. Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth[J]. Mol Pharm，2010，7(3)：775-785.

[43] Wang J，Teng Y，Hao Y，et al. Preparation and properties of polyamines：part II controlled and sustained release of nitric oxide(NO) from nitrosated polymers[J]. Polym J，2009，41(9)： 715-725.

[44] Friedman AJ，Han G，Navati MS，et al. Sustained release nitric oxide releasing nanoparticles：characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites [J]. Nitric Oxide，2008，19(1)：12-20.

[45] Hien T，Duong T，Kamarudin ZM，et al. Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers [J]. Chem Commun：Camb，2013，49(39)：4190-4192.

[46] Giles NM，Kumari S，Gang BP，et al. The molecular design of S-nitrosothiols as photodynamic agents for controlled nitric oxide release[J]. Chem Biol Drug Des，2012，80(3)：471-478.